Microbiome Landscape Start-up Funding Analytics 2020

DUBLIN, Dec. 17, 2020 /PRNewswire/ -- The "2020 Startup Funding Analytics of the Microbiome Landscape" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

This module captures the analytics associated with startup funding activity in the Microbiome space over several years (2015-2020). It helps understand startup activity in not just human health but also across industries such as Agriculture, Food & Beverage to unravel investor enthusiasm in this space. Trends captured include investments in microbiome companies over time; Distribution by geography, funder type, funding round; Allocation by industry, disease area; Top 5 investors; Top companies that have raised the most capital.

This module is a rigorous assessment of the industry trends supported by detailed segmentation across publications, grants, clinical trials, and startup funding activity. The dataset behind the report is based on real world evidence that will drive actionable business insights.

Follow trends over the years captured across publications, grants, clinical trials, and startup funding activity to power data driven marketing campaigns to fund raising to investor pitches, and business/corporate development activities. Tap into premium data sources that leverage NLP and relational search paradigm to uncover relevant data points, all in one package.

Over 40K scientific publications, >3K grants, and 100s of trials and funding activities have been analyzed to provide firms with actionable business insights.

The report is unique in focusing on the real-world evidence of activity and uptake within these four pillars:

    --  Publication of scientific papers focused on microbiome research has been
        surging. A Chinese funding agency is the leading body that has been
        supporting a lot of published research, this is especially notable given
        the current contentious climate with China.
    --  Microbiome research grants continue to increase. Infectious disease and
        cancer researchers are the top award recipients. The US and EU have the
        most funding.
    --  COVID-19 has not dented the number of ongoing clinical trials focused on
        the microbiome. It has an unprecedented influence in the field of
        Oncology trials. Infectious disease is the main one in the microbiome
        pipeline is focused on a wide variety of indications.
    --  Exponential growth in investment has been seen in microbiome focused
        companies. 2020 has been a landmark time for the field of microbiome
        with investors betting big in companies in agriculture, food, and
        infectious disease.

Key Topics Covered:

Microbiome Based startup Activity (2015-2020)

    --  Investment trend
    --  Distribution by countries
    --  Distribution by funder type and funding round
    --  Microbiome investing by industry and disease area
    --  Top 5 Investors
    --  Top 3 companies from 2015-2020 that have raised the most capital

For more information about this report visit https://www.researchandmarkets.com/r/usozbw

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/microbiome-landscape-start-up-funding-analytics-2020-301195091.html

SOURCE Research and Markets